Clinical Trial Update: Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating imatinib mesylate in combination with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia
• Mixed Phenotype Acute Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Gleevec (Imatinib)
• Imatinib mesylate (Imatinib)

Snippet

Sponsor: Children's Oncology Group | Conditions: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING